Abstract: Generally, in a non-destructive test application, a compressed representation of an acoustic echo signal acquired by a non-destructive test (NDT) probe assembly can be received, such as via a network. The compressed representation can include data indicative of changes in phase values of the acoustic echo signal. Using the compressed representation, a time-domain representation of an instantaneous phase signal can be constructed from the compressed representation. The constructed instantaneous phase signal can be used in constructing at least one of an uncompressed acoustic echo signal representation or an image. As an illustration, amplitude values of sampled acoustic echo signals can be suppressed in the compressed representation, reducing data volume associated with transmitting a representation of the acquired acoustic echo signal.

Abstract: The use of compositions comprising a papaya mosaic virus (PapMV) moiety for stimulation of the innate immune response is provided. The PapMV moiety may be papaya mosaic virus or PapMV virus-like particles (VLPs). The PapMV compositions stimulate a sufficiently strong innate immune response to provide protection against subsequent pathogen challenge or to treat an established infection. The use of PapMV compositions to protect a subject from potential infection by a pathogen, such as a viral pathogen, a bacterial pathogen or a fungal pathogen, and the use of PapMV compositions to treat an established infection, are also provided. The PapMV compositions be administered, for example, via intranasal or pulmonary routes to elicit effects within the mucosa and/or in the respiratory system.

Abstract: Papaya mosaic virus and virus-like particles (VLPs) comprising ssRNA for use to inhibit cancer growth and metastasis. The PapMV and PapMV VLPs may be used alone or in combination with another cancer therapy, such as a chemotherapeutic, immunotherapeutic, or radiotherapy.

Abstract: An immunopotentiating composition comprising a papaya mosaic virus (PapMV), or a virus-like particle (VLP) derived from PapMV coat protein, which is capable of functioning as an adjuvant and thus potentiating an immune response in an animal is provided. The immunopotentiating composition can further comprise an immunogen, which can be fused or otherwise linked to the VLP, or not linked to the VLP. The immunopotentiating composition is capable of potentiating a humoral and/or a cellular response in the animal and is suitable for use as an adjuvant or vaccine. Methods of potentiating an immune response in an animal comprising administering to the animal an immunopotentiating composition are also provided have application in both human and veterinary medicine.

Abstract: The modular shelving system includes a shelf assembly having a plurality of elongated horizontally-extending side rails. At least some of the side rails include at least one open-ended first through slot, each first through slot extending lengthwise on a horizontally-projecting side rail strip along a common junction from a corresponding one of the side rail ends. The shelving system also includes a plurality of elongated vertically-extending corner posts to which the side rail ends are connected to form a self-standing skeletal structure. Each corner post has at least two open-ended second through slots located at a given distance in-between the corner post ends and that each extend perpendicularly from a corresponding side edge towards a common junction of the corner post. Each first through slot forms a detachable interdigitated and load-bearing engagement with a corresponding one of the second through slots to support the shelf assembly.

Abstract: The modular shelving system includes a shelf assembly having a plurality of elongated horizontally-extending side rails. At least some of the side rails include at least one open-ended first through slot, each first through slot extending lengthwise on a horizontally-projecting side rail strip along a common junction from a corresponding one of the side rail ends. The shelving system also includes a plurality of elongated vertically-extending corner posts to which the side rail ends are connected to form a self-standing skeletal structure. Each corner post has at least two open-ended second through slots located at a given distance in-between the corner post ends and that each extend perpendicularly from a corresponding side edge towards a common junction of the corner post. Each first through slot forms a detachable interdigitated and load-bearing engagement with a corresponding one of the second through slots to support the shelf assembly.

Abstract: The use of compositions comprising a papaya mosaic virus (PapMV) moiety for stimulation of the innate immune response is provided. The PapMV moiety may be papaya mosaic virus or PapMV virus-like particles (VLPs). The PapMV compositions stimulate a sufficiently strong innate immune response to provide protection against subsequent pathogen challenge or to treat an established infection. The use of PapMV compositions to protect a subject from potential infection by a pathogen, such as a viral pathogen, a bacterial pathogen or a fungal pathogen, and the use of PapMV compositions to treat an established infection, are also provided. The PapMV compositions be administered, for example, via intranasal or pulmonary routes to elicit effects within the mucosa and/or in the respiratory system.

Abstract: An immunopotentiating composition comprising a papaya mosaic virus (PapMV), or a virus-like particle (VLP) derived from PapMV coat protein, which is capable of functioning as an adjuvant and thus potentiating an immune response in an animal is provided. The immunopotentiating composition can further comprise an immunogen, which can be fused or otherwise linked to the VLP, or not linked to the VLP. The immunopotentiating composition is capable of potentiating a humoral and/or a cellular response in the animal and is suitable for use as an adjuvant or vaccine. Methods of potentiating an immune response in an animal comprising administering to the animal an immunopotentiating composition are also provided have application in both human and veterinary medicine.

Abstract: An immunopotentiating composition comprising a papaya mosaic virus (PapMV), or a virus-like particle (VLP) derived from PapMV coat protein, which is capable of functioning as an adjuvant and thus potentiating an immune response in an animal is provided. The immunopotentiating composition can further comprise an immunogen, which can be fused or otherwise linked to the VLP, or not linked to the VLP. The immunopotentiating composition is capable of potentiating a humoral and/or a cellular response in the animal and is suitable for use as an adjuvant or vaccine. Methods of potentiating an immune response in an animal comprising administering to the animal an immunopotentiating composition are also provided have application in both human and veterinary medicine.

Abstract: An immunopotentiating composition comprising a papaya mosaic virus (PapMV), or a virus-like particle (VLP) derived from PapMV coat protein, which is capable of functioning as an adjuvant and thus potentiating an immune response in an animal is provided. The immunopotentiating composition can further comprise an immunogen, which can be fused or otherwise linked to the VLP, or not linked to the VLP. The immunopotentiating composition is capable of potentiating a humoral and/or a cellular response in the animal and is suitable for use as an adjuvant or vaccine. Methods of potentiating an immune response in an animal comprising administering to the animal an immunopotentiating composition are also provided have application in both human and veterinary medicine.